Zoledronic Acid After Percutaneous Kyphoplasty for Osteoporotic Fx Improves Pain, Disability & BMD
How to Cite
OrthoEvidence. Zoledronic Acid After Percutaneous Kyphoplasty for Osteoporotic Fx Improves Pain, Disability & BMD. ACE Report. 2021;34(1):1. Available from: https://myorthoevidence.com/AceReport/Report/13570
Clinical efficacy of zoledronic acid combined with percutaneous kyphoplasty in the prevention and treatment of osteoporotic vertebral compression fracture: A systematic review and meta-analysisMedicine (Baltimore). 2021 Apr 2;100(13): e25215.
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Eight randomized controlled trials including 578 patients with osteoporotic vertebral compression fracture who underwent percutaneous kyphoplasty were randomized to undergo zoledronic acid injections (n=285) or no treatment (n=293). Primary outcomes included bone mineral density (BMD), pain on the visual analogue scale (VAS), disability using the Oswestry Disability Index (ODI), incidence of recom...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE